Gilles Forte

Essential medicines for cancer: WHO recommendations and national priorities

Jane Robertson, Ronald D. Barr, Lawrence N. Shulman et al. · Bulletin of the World Health Organization · 2016 · 118 citations · Full text

Public Affairs, Oncology, Pharmaceutical Policy +15

Increasing transparency and accountability in national pharmaceutical systems

Anne Paschke, Deirdre Dimancesco, Taryn Vian et al. · Bulletin of the World Health Organization · 2018 · 60 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +15

Medicines availability for non-communicable diseases: the case for standardized monitoring

Jane Robertson, Cécile Macé, Gilles Forte et al. · Globalization and Health · 2015 · 55 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +16

Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

Taryn Vian, Jillian Clare Köhler, Gilles Forte et al. · Journal of Pharmaceutical Policy and Practice · 2017 · 55 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +16

Medicines for cancers in children: The WHO model for selection of essential medicines

Jane Robertson, Nicola Magrini, Ronald D. Barr et al. · Pediatric Blood & Cancer · 2015 · 31 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +15